EMEA-000700-PIP02-10

Key facts

Invented name
Galvus
Active substance
vildagliptin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/177/2011
PIP number
EMEA-000700-PIP02-10
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of Type II diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Limited
Switzerland
paediatric.enquiries@novartis.com
Phone: +41 61 324 1111
Fax: +41 61 324 8001
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating
Average
1 rating